NCT05816980View on ClinicalTrials.gov

Re-irradiation for Pelvic Recurrences in Rectal Cancer Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2023

Conditions
Rectal CancerRecurrenceRadiation Toxicity
Interventions
RADIATION

Hyperfractionated external beam radiation

40.8Gy/34 fractions (1.2Gy BID 5/7 days with minimum 6 hours interval) Concurrent capecitabine (825 mg/m2 BID 5/7 days)

Trial Locations (2)

8000

Aarhus University Hospital, Aarhus

0424

Oslo University Hospital, Oslo

All Listed Sponsors
collaborator

Oslo University Hospital

OTHER

lead

Aarhus University Hospital

OTHER

NCT05816980 - Re-irradiation for Pelvic Recurrences in Rectal Cancer Patients | Biotech Hunter | Biotech Hunter